Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2303)	7/17/1999 9:49:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 10293

GUMM is a stock promotion scheme based on fraudulent misrepresentations of Zicam as a safe and effective remedy for the common cold. Zicam is classified as a "homeopathic" medication - as are all other quack remedies that can't support their claims with scientific evidence. GUMM's fraudulent misrepresentation of Zicam is simply another story in a long line of medical "miracle cure" frauds that pop up on a daily basis in supermarket tabloid advertisements and late night infomercials. GUMM stock is grossly overvalued and investors considering purchasing the stock should be aware that management is directly involved in this fraudulent scheme.